Press Releases
Oxonica signs NANOPLEX™ agreement with leading global medical technology.
Test Location - 22nd August 2006
Oxonica announces that it has signed a licence agreement for its NANOPLEX™ technology with BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in New Jersey, USA.
Oxonica awarded ISO9001 certification
- 14th March 2006
Oxonica plc, a leading International nanomaterials group, is delighted to announce that it has been awarded ISO9001 certification for its UK based activities in the research and development, manufacture and supply of innovative commercial solutions in nanomaterials and associated consultative services.
Acquisition of Nanoplex Technologies Inc
- 20th December 2005
Oxonica plc, a leading European nanotechnology group, today announces that it has signed an agreement to acquire US based Nanoplex Technologies Inc for a total consideration of up to 7,538,440 fully paid ordinary shares in Oxonica, which is equivalent to approximately 17% of the equity of the enlarged group.
Oxonica and Croda form parnership to drive Oxonica's UV absorber Optisol™ into the global cosmetics market
Oxford, UK - 15th December 2005
Oxonica plc, a leading European nanotechnology group, is pleased to announce that it has signed an exclusive agreement with Croda, a global speciality chemicals group, to distribute Oxonica’s Optisol™ UV absorber into the international personal care market.
Oxonica’s Successful Placing on AIM
- 20th July 2005
Oxford, UK
Oxonica plc, the holding company of one of Europe’s leading nanomaterials groups, announces that following a successful placing, its ordinary shares will commence trading on AIM today.